Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Vaishali Pharma Ltd Fixes Record Date for 1 to 1 Bonus Issue and 1 to 5 Stock Split Business
  • Mohammad Jamaluddin to Join Jan Suraaj Launch, Backs Prashant Kishore’s Vision for Bihar National
  • Monteria Village to organise ‘Utsav Maharashtra’, A festival to Experience the Culture and Legacy of Maharashtra Business
  • Alieus Hedge Fund Achieves Remarkable Milestone, Raising INR 100 Crore in Just 4 Months in December 2024 Business
  • Avani Institute of Design Hosts the 66th ZNC Meeting Education
  • BOLD – Big On Luxe Deals, an exclusive shopping experience for designer labels By Nykaa Fashion Luxe Business
  • Whitelion Introduces Revolutionary ‘Air Series’ Home Automation Solutions Business
  • Encompass Expands Home Décor Portfolio With The Launch Of Blisshome, A Smart, Design-Led Bedding Brand For Aspirational Younger Affluent Indians Business

A birth defect in his spine and now a rare disease! 15-month old Nirvaan needs INR 17.5 cr to battle SMA

Posted on February 20, 2023 By

Mumbai (Maharashtra) [India], February 20: When a child is born, it is an occasion of happiness for everyone around. Sadly for the Mumbai-based Menon family, the joy lasted only for moments until they realised their beloved son Nirvaan was born with a birth defect- Congenital Scoliosis. Later during tests, he was diagnosed with a rare genetic disorder- Spinal Muscular Atrophy (SMA) – Type 2. This deadly disease has taken away his ability to eat, walk or breathe. The family has joined hands with the crowdfunding platform ImpactGuru.com and is raising INR 17.5 crores for their son’s treatment.

Nirvaan suffers from Spinal Muscular Atrophy (SMA) Type-2, and his condition is progressive, which means that with each passing day, his condition worsens. To help him battle this disorder, the gene therapy that shows hope is Zolgensma. To avail of this therapy, the child should be within the age limit of 2 years. Hence, it is necessary to fight against the clock and save Nirvaan’s life.

“Spinal Muscular Atrophy, a disease we had never heard of, has held our child under its clutches. We are more than willing to take all steps and knock at all doors that can help our Nirvaan. Because INR 17+ crores is a huge amount for any middle-class family to afford, we cannot lose our beloved child. Every contribution made will help us give Nirvaan his childhood back,” said Sarang, Nirvaan’s father.

What is SMA-2?

Spinal Muscular Atrophy – Type 2 or SMA-2 is a genetic neuromuscular disorder that affects the nerve cells that control voluntary muscles (motor neurons). If not treated, the progressive muscles become weak and eventually restrict any muscular movement. Babies with SMA-2 can sit without support. However, they cannot walk or stand unassisted.

The raised amount on Impact Guru, an online medical fundraising platform, will be used for Nirvaan’s ongoing treatment and dose of Zolgensma Therapy.

The single highest donation received on the crowdfunding campaign in INR is approximately 1 crore. All details are mentioned in the fundraiser link: (https://www.impactguru.com/fundraiser/help-nirvaan-a-menon)

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: ORRA Jewellery outshines all others by winning 5 million Hearts this Valentine’s Day
Next Post: Mr. Digant Sharma, CMD of Francture Brands has done Sole-tie-up with renowned Russian Refinery for Crude oil, LPG, LNG, Diesel and more

Related Posts

  • Gujarat is all set to host the first ever India’s biggest annual conference 30th IPA Congress and the 60th PEDICON Business
  • Ahmedabad’s ultimate business expo Atlas ProBiz 2.0 begins Business
  • GLEN Industries Limited IPO To Open On 08th July, Sets Price Band At Rs 92 to Rs 97 Per Share Business
  • Revolutionizing Indian Agriculture: AutoNxt’s Electric Tractors Bring Intelligence, Sustainability, and Profitability to Farmers Business
  • Mindbowser Welcomes Manisha, An Accomplished Marketer and Strategic Leader as CMO Business
  • Film-E-Life! Make Your Life a Blockbuster Business

Recent Posts

  • Magellanic Cloud Continues Order Momentum with Fresh Order for AI-Powered Railway Surveillance from South Central Railway
  • Jamboree Education Expands Its Reach With Launch of Four New Centres in Mumbai, Delhi, Pune
  • IFCCI Luxury Committee and Comité Colbert sign landmark MoU in Paris
  • Virtuoso Optoelectronics Moves to the NSE and BSE Main Boards, Strengthening Its Growth Journey
  • India Isn’t Catching Up to APAC’s Office Market. It’s Leading It.

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • New Age Mompreneurs Brings Shoppers Delight with Rakhi Edit Exhibition Business
  • POP-UP Announcement: Aseem Kapoor label makes their Kanpur debut with Amiraah multi-designer store, exclusively Business
  • LSE & FourthRev Collaborate with TimesPro to Launch Business Analytics Certificate for Executives Education
  • It’s Obvious: Beat Street Will Be the Biggest Street Food, Culture & Music Festival! Lifestyle
  • Guthli Ad Fest by Miles SOBA Sees 100 Universities Unite, Celebrating Icons Piyush Pandey and KV Sridhar Education
  • IMS Ghaziabad (University Courses Campus) E-Cell Ignites Entrepreneurial Spirit at E-Summit 2024 Education
  • Investors Can Apply in the IPO of ‘Shlokka Dyes Limited’ Till 6 October 2025 Business
  • Rhetan TMT Limited: Building Scale, Margin Strength, and Market Interest Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme